NA
Therapeutic Areas
Cullinan Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CLN-978 | Systemic Lupus Erythematosus (SLE) | Phase 1 |
| Zipalertinib (CLN-081/TAS6417) | Relapsed EGFR exon 20 insertion NSCLC | NDA Submission |
| CLN-049 | Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) | Phase 1/2 |